SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Envision Healthcare Corporation (EVHC)

NEW YORK, July 25, 2017 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Envision Healthcare Corporation ("Envision" or the "Company') (NYSE: EVHC). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/evhc.

The investigation concerns whether Envision and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On July 24, 2017, The New York Times published an article stating that doctors associated with Envision's subsidiary EmCare Holdings Inc. were extremely likely to engage in "surprise billing," in which patients who go to in-network hospitals are treated by out-of-network doctors and then billed at higher rates. Following this news, Envision stock dropped $2.33 per share, or 3.72%, to close at $60.28 on July 24, 2017.

If you are aware of any facts relating to this investigation, or purchased shares of Envision, you can assist this investigation by visiting the firm's site: www.bgandg.com/evhc. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

SOURCE Bronstein, Gewirtz & Grossman, LLC

Related Links

http://www.bgandg.com